Girin Pascal E R 4

What Happened
Pascal E.R. Girin, a non‑employee director of ClearPoint Neuro, received a grant/award of 755 shares of CLPT common stock on April 1, 2026. The shares were issued at $9.10 per share (the closing price on March 31, 2026), for a total value of $6,871. The transaction is reported on a Form 4 as an acquisition/award (code A).

Key Details

• Transaction date: April 1, 2026; filing date: April 2, 2026 (filed within one business day; timely).
• Price per share: $9.10; total value: $6,871.
• Shares issued: 755 shares.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: Shares were issued pursuant to the issuer’s Sixth Amended and Restated 2013 Incentive Compensation Plan in payment of fees owed under the issuer’s Non‑Employee Director Compensation Plan; issued at the March 31, 2026 closing price.

Context
This was a compensatory grant issued in lieu of director fees, a routine form of non‑employee director compensation. Such awards are standard and do not, by themselves, indicate the insider’s market view.